Multiple Myeloma Connect
  • Saved

Reporter/Multiple Myeloma/car-t-cell-therapies-bispecific-antibodies-and-antibody-conjugates

CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates

CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates

Source : https://expertperspectives.com/Conference

Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance

  • Saved

An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma

An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma

Source : https://doi.org/10.1080/14712598.2021.1872540

ABSTRACT Introduction: B-cell maturation antigen (BCMA) targeted therapy (BCMA-TT) has emerged as a promising treatment for Multiple Myeloma (MM). the three most common treatment modalities for targeting BCMA are antibody-drug...

  • Saved

Imaging Techniques for Response Assessment and Follow-Up

Imaging Techniques for Response Assessment and Follow-Up

Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_5

Leo Rasche Anke Heidemeier Stefan Delorme Niels Weinhold A recent study in newly diagnosed multiple myeloma (MM) patients revealed that high-risk tumor clones can be restricted to focal lesions (FLs)...

  • Saved

New Perspectives in Imaging Techniques

New Perspectives in Imaging Techniques

Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_6

Bastien Jamet Clément Bailly Thomas Carlier Anne-Victoire Michaud Cyrille Touzeau Philippe Moreau Caroline Bodet-Milin Françoise Kraeber-Bodéré The development of nuclear medicine offers new perspectives in multiple myeloma (MM) imaging. New...

  • Saved

Treatment of Multiple Myeloma with Kidney Involvement

Treatment of Multiple Myeloma with Kidney Involvement

Source : https://link.springer.com/chapter/10.1007/978-3-030-63662-3_10

Mark A. Cook In many respects, the treatment of myeloma in patients with kidney involvement and renal impairment has the same goal as any other patient group being treated for...